Combination Elotuzumab and Lenalidomide Treatment Efficacy Is Dependent on Crosstalk between NK Cells, Monocytes and Myeloma Cells

Researchers used a humanized myeloma mouse model and adoptive transfer of human NK cells to show that elotuzumab and lenalidomide treatment controlled myeloma growth, and this was mediated through CD16 on NK cells.

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News